Literature DB >> 16563233

Caveolin-3 inhibits growth signal in cardiac myoblasts in a Ca2+-dependent manner.

Takayuki Fujita1, Kouji Otsu, Jin Oshikawa, Hideaki Hori, Hitoshi Kitamura, Takaaki Ito, Satoshi Umemura, Susumu Minamisawa, Yoshihiro Ishikawa.   

Abstract

Caveolin, a major protein component of caveolae, directly interacts with multiple signaling molecules, such as Ras and growth factor receptors, and inhibits their function. However, the role of the second messenger system in mediating this inhibition by caveolin remains poorly understood. We examined the role of Ca2+-dependent signal in caveolin- mediated growth inhibition using a rat cardiac myoblast cell line (H9C2), in which the expression of caveolin- 3, the muscle specific subtype, can be induced using the LacSwitch system. Upon induction with IPTG and serum-starvation, the expression of caveolin-3 was increased by 3.3-fold relative to that of mock-induced cells. The recombinant caveolin-3 was localized to the same subcellular fraction as endogenous caveolin-3 after sucrose gradient purification. Angiotensin II enhanced ERK phosphorylation, but this enhancement was significantly decreased in caveolin-3-induced cells in comparison to that in mock-induced cells. Similarly, when cells were stimulated with fetal calf serum, DNA synthesis, as determined by [3H]-thymidine incorporation, was significantly decreased in caveolin- 3-induced cells. When cells were treated with Ca2+ chelator (BAPTA and EGTA), however, this attenuation was blunted. Calphostin (PKC inhibitor), but not cyclosporine A treatment (calcineurin inhibitor), blunted this attenuation in caveolin-3 induced cells. Our findings suggest that caveolin exhibits growth inhibition in a Ca2+-dependent manner, most likely through PKC, in cardiac myoblasts.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16563233      PMCID: PMC3933113          DOI: 10.1111/j.1582-4934.2006.tb00302.x

Source DB:  PubMed          Journal:  J Cell Mol Med        ISSN: 1582-1838            Impact factor:   5.310


  23 in total

Review 1.  Cytoplasmic signaling pathways that regulate cardiac hypertrophy.

Authors:  J D Molkentin; G W Dorn
Journal:  Annu Rev Physiol       Date:  2001       Impact factor: 19.318

2.  Targeted inhibition of calcineurin prevents agonist-induced cardiomyocyte hypertrophy.

Authors:  T Taigen; L J De Windt; H W Lim; J D Molkentin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

Review 3.  Protein kinase C isoform-selective signals that lead to cardiac hypertrophy and the progression of heart failure.

Authors:  Abdelkarim Sabri; Susan F Steinberg
Journal:  Mol Cell Biochem       Date:  2003-09       Impact factor: 3.396

4.  Caveolin interaction with protein kinase C. Isoenzyme-dependent regulation of kinase activity by the caveolin scaffolding domain peptide.

Authors:  N Oka; M Yamamoto; C Schwencke; J Kawabe; T Ebina; S Ohno; J Couet; M P Lisanti; Y Ishikawa
Journal:  J Biol Chem       Date:  1997-12-26       Impact factor: 5.157

5.  Inhibition of adenylyl cyclase by caveolin peptides.

Authors:  Y Toya; C Schwencke; J Couet; M P Lisanti; Y Ishikawa
Journal:  Endocrinology       Date:  1998-04       Impact factor: 4.736

6.  Inhibition of PKCalpha and rhoA translocation in differentiated smooth muscle by a caveolin scaffolding domain peptide.

Authors:  M J Taggart; P Leavis; O Feron; K G Morgan
Journal:  Exp Cell Res       Date:  2000-07-10       Impact factor: 3.905

7.  Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study.

Authors:  D Levy; R J Garrison; D D Savage; W B Kannel; W P Castelli
Journal:  N Engl J Med       Date:  1990-05-31       Impact factor: 91.245

8.  Src tyrosine kinases, Galpha subunits, and H-Ras share a common membrane-anchored scaffolding protein, caveolin. Caveolin binding negatively regulates the auto-activation of Src tyrosine kinases.

Authors:  S Li; J Couet; M P Lisanti
Journal:  J Biol Chem       Date:  1996-11-15       Impact factor: 5.157

9.  Expression of caveolin-3 in skeletal, cardiac, and smooth muscle cells. Caveolin-3 is a component of the sarcolemma and co-fractionates with dystrophin and dystrophin-associated glycoproteins.

Authors:  K S Song; P E Scherer; Z Tang; T Okamoto; S Li; M Chafel; C Chu; D S Kohtz; M P Lisanti
Journal:  J Biol Chem       Date:  1996-06-21       Impact factor: 5.157

10.  Co-stimulation-dependent activation of a JNK-kinase in T lymphocytes.

Authors:  A Avraham; S Jung; Y Samuels; R Seger; Y Ben-Neriah
Journal:  Eur J Immunol       Date:  1998-08       Impact factor: 5.532

View more
  7 in total

Review 1.  Caveolae as organizers of pharmacologically relevant signal transduction molecules.

Authors:  Hemal H Patel; Fiona Murray; Paul A Insel
Journal:  Annu Rev Pharmacol Toxicol       Date:  2008       Impact factor: 13.820

Review 2.  Viral-mediated gene therapy for the muscular dystrophies: successes, limitations and recent advances.

Authors:  Guy L Odom; Paul Gregorevic; Jeffrey S Chamberlain
Journal:  Biochim Biophys Acta       Date:  2006-09-26

3.  Dysfunctional survival-signaling and stress-intolerance in aged murine and human myocardium.

Authors:  Jason N Peart; Salvatore Pepe; Melissa E Reichelt; Nikkie Beckett; Louise See Hoe; Victoria Ozberk; Ingrid R Niesman; Hemal H Patel; John P Headrick
Journal:  Exp Gerontol       Date:  2013-12-04       Impact factor: 4.032

4.  Lipid raft in cardiac health and disease.

Authors:  Manika Das; Dipak K Das
Journal:  Curr Cardiol Rev       Date:  2009-05

5.  Lactosylceramide promotes hypertrophy through ROS generation and activation of ERK1/2 in cardiomyocytes.

Authors:  Sumita Mishra; Subroto Chatterjee
Journal:  Glycobiology       Date:  2014-03-21       Impact factor: 4.313

6.  Hyperglycemia-induced protein kinase C β2 activation induces diastolic cardiac dysfunction in diabetic rats by impairing caveolin-3 expression and Akt/eNOS signaling.

Authors:  Shaoqing Lei; Haobo Li; Jinjin Xu; Yanan Liu; Xia Gao; Junwen Wang; Kwok F J Ng; Wayne Bond Lau; Xin-Liang Ma; Brian Rodrigues; Michael G Irwin; Zhengyuan Xia
Journal:  Diabetes       Date:  2013-03-08       Impact factor: 9.461

7.  The effect of Cyclosporine A on cardiomyocytes differentiation.

Authors:  Liliana Paslaru; Sean Davidson; Irinel Popescu; Michel Morange
Journal:  J Cell Mol Med       Date:  2007 Mar-Apr       Impact factor: 5.310

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.